Abstract
The uroprotectant thiol mesna was found to protect adult CD-1 mice from high-dose cisplatin lethality. Mesna doses of 50 mg/kg were given with cisplatin, or 5 min after cisplatin (25 or 30 mg/kg) and acute survival was increased in non-tumor-bearing mice. In contrast, mesna mixed directly with cisplatin significantly reduced cisplatin antitumor effects in DBA/2J mice given 106 P-388 leukemia i.p. Mesna administered i.p. 5 min after cisplatin (6,8 or 10 mg/kg) did not reduce cisplatins' antitumor efficacy in this same tumor model. Mesna appears to inactivate cisplatin directly in vitro but possibly not in vivo if separate injections are used.
Original language | English (US) |
---|---|
Pages (from-to) | 604-605 |
Number of pages | 2 |
Journal | Journal of Cancer Research and Clinical Oncology |
Volume | 115 |
Issue number | 6 |
DOIs | |
State | Published - Nov 1989 |
Keywords
- Cisplatin
- Mesna
- Mice
ASJC Scopus subject areas
- Oncology
- Cancer Research